TMBIM6 antagonist-1
CAS No. 123134-61-2
TMBIM6 antagonist-1( BIA )
Catalog No. M22371 CAS No. 123134-61-2
TMBIM6 antagonist-1 is an antagonist of TMBIM6.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 201 | In Stock |
|
| 2MG | 117 | In Stock |
|
| 5MG | 187 | In Stock |
|
| 10MG | 315 | In Stock |
|
| 25MG | 567 | In Stock |
|
| 50MG | 792 | In Stock |
|
| 100MG | 1088 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2186 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTMBIM6 antagonist-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionTMBIM6 antagonist-1 is an antagonist of TMBIM6.
-
DescriptionTMBIM6 antagonist-1 is an antagonist of TMBIM6.
-
In VitroCell Viability Assay Cell Line:HT1080, MCF7, MDA-MB-2341 and SKBR3 cells.Concentration:0.5-10 μM.Incubation Time:3 days.Result:Inhibited cell viability.Western Blot Analysis Cell Line:WT and TMBIM6 KO HT1080 cells.Concentration:0, 2, 5 μM.Incubation Time:Result:Downregulated the protein levels of AKT-pS473.
-
In VivoAnimal Model:Six- to eight-week BklNbt:BALB/c/nu/nu old mice (HT1080 and MDA-MB-231 cells).Dosage:1?mg/kg.Administration:IP 5 days per week during 25 days.Result:Impaired cell-driven tumor growth.
-
SynonymsBIA
-
PathwayPI3K/Akt/mTOR signaling
-
TargetmTOR
-
RecptorTMBIM6
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number123134-61-2
-
Formula Weight268.27
-
Molecular FormulaC15H12N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (186.38 mM)
-
SMILESNc1ccccc1C(=O)\C=C\c1cccc(c1)[N+]([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kim H K , Bhattarai K R , Junjappa R P , et al. TMBIM6/BI-1 contributes to cancer progression through assembly with mTORC2 and AKT activation[J]. Nature Communications, 2020, 11(1).
molnova catalog
related products
-
AZD 3147
AZD 3147 is an inhibitor of mTORC with IC50s of 40.7 and 5.75 nM for mTORC1 and mTORC2. AZD 3147 shows IC50s of 912, 5495, 9333, and 6310 nM for PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ, respectively.
-
WYE-125132
A potent, specific, ATP-competitive and orally active mTOR inhibitor with IC50 of 0.19 nM.
-
Autogramin-1
Autogramin-1 potently inhibits starvation-induced autophagy with IC50 of 0.17 μM.
Cart
sales@molnova.com